Current Status of Porcine Derived Products in Surgery

Sponsor
Ankara University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04664452
Collaborator
(none)
500
4.5

Study Details

Study Description

Brief Summary

Porcine derived products are being used as biological grafts in mainly in orthopedic surgery, neurosurgery, cardiovascular surgery and general surgery. It is well known that consuming pork or porcine products are prohibited in some religions or divisions of religions. It may be a tender point for patients undergoing surgery in which porcine derived products are utilized.In this survey study we aimed to determine the level of awareness and perception of surgeons with an international anquette. The study will also reveal the choices of surgeons about this issue both in elective and emergency procedures

Condition or Disease Intervention/Treatment Phase
  • Other: Questionnaire

Detailed Description

In the survey study an online anquette form will be sent through online surgery networks both professional and social media. The questionnaire will not include questions defining the responders individually. The questions are related to frequency of utilization of porcine derived products in surgery, surgeons' level of awareness about utilization of porcine products, surgeons' level of religiousity and surgeons' choices about porcine derived product utilization and consent of patients. After collection of responses the data will be analyzed to discover current status of porcine derived surgical product utilization and surgeons' perception about the issue. The anquette will be distributed worldwide to surgeons in different branches of surgery. Literature seems to be lacking of that kind of study

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Current Status of Utilization an Surgeons' View of Porcine Derived Medical Products: an International Survey
Anticipated Study Start Date :
May 5, 2021
Anticipated Primary Completion Date :
Aug 20, 2021
Anticipated Study Completion Date :
Sep 20, 2021

Outcome Measures

Primary Outcome Measures

  1. Surgeons' awareness of utilization of porcine derived products in surgery [2 month]

    Frequency of awareness and experience on porcine derived medical products

  2. Surgeons' choice about utilization of porcine derived products in surgery [2 month]

    Choices of surgeons on specific scenarios in the questionnaire

Secondary Outcome Measures

  1. Relationship of porcine derived product utilization according to religious/phlosophical belief [2 month]

    Choices of surgeons according to Religiousness Scale of Altemayer

  2. Surgeons' choice about informing patients about porcine derived products [2 month]

    What ar e the choices of surgeons about informing patients and their relatives in described scenarios in the questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Being volunteer and responder of at least 80% of the study questionnaire
Exclusion Criteria:
  • Responding less than 80% of the questionnaire

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Ankara University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Elvan Onur Kirimker, Attending Surgeon at Dept of Surgery, Ankara University
ClinicalTrials.gov Identifier:
NCT04664452
Other Study ID Numbers:
  • PORCINE2020
First Posted:
Dec 11, 2020
Last Update Posted:
May 6, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Elvan Onur Kirimker, Attending Surgeon at Dept of Surgery, Ankara University

Study Results

No Results Posted as of May 6, 2021